Vaxart
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $6,401 | $2,181 | $3,245 | $446 |
Gross Profit | 5,301 | 1,081 | 2,045 | -754 |
EBITDA | -15,156 | -22,970 | -15,700 | -15,089 |
EBIT | -16,256 | -24,070 | -16,900 | -16,289 |
Net Income | -16,466 | -24,417 | -17,375 | -17,400 |
Net Change In Cash | 6,401 | 2,181 | 3,245 | 446 |
Free Cash Flow | -12,397 | -21,322 | -13,417 | -15,283 |
Cash | 43,285 | 26,735 | 34,755 | 32,448 |
Basic Shares | 184,703 | 168,811 | 153,452 | 152,026 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $7,379 | $107 | $892 | $4,046 |
Gross Profit | 2,879 | -3,160 | -47,857 | -15,817 |
EBITDA | -78,847 | -96,321 | -61,669 | -28,234 |
EBIT | -83,347 | -99,588 | -64,101 | -30,080 |
Net Income | -82,465 | -107,758 | -70,470 | -32,220 |
Net Change In Cash | 7,379 | 107 | 892 | 4,046 |
Cost of Revenue | -97,732 | 16,875 | 113,344 | |
Free Cash Flow | -72,324 | -104,380 | -64,989 | -24,973 |
Cash | 34,755 | 44,013 | 143,745 | 126,870 |
Basic Shares | 144,819 | 127,683 | 121,453 | 88,295 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.09 |
2024-03-31 | -$0.14 |
2023-12-31 | -$0.12 |
2023-09-30 | -$0.11 |
